Chief Financial Officer of Epizyme, Inc. (NASDAQ:EPZM), Agarwal Shefali, sells 969 shares worth $10,862

According to Epizyme, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 05 04:41 PM, company Chief Financial Officer, Agarwal Shefali disclosed selling 969 shares at a cost of $11.21. At the time of this transaction (Feb 04), this trade was worth $10,862 in total. As of Feb 04, Agarwal Shefali now owns 104,341 shares in total worth about $1,146,707.59.

For the last few recent trades made by Epizyme, Inc. (NASDAQ:EPZM) Chief Financial Officer, Agarwal Shefali, we have the following information:

  1. SEC Form 4 filing: Jan 25: Sold 2,872 shares at the rate of $11.41 per share. Total worth of this trade was $32,770. Total number of shares owned as of Jan 25 were 75,727
  2. SEC Form 4 filing: Dec 03: Sold 2,522 shares at the rate of $13.54 per share. Total worth of this trade was $34,148. Total number of shares owned as of Dec 03 were 76,089
  3. SEC Form 4 filing: Jun 26: Sold 1,805 shares at the rate of $16.15 per share. Total worth of this trade was $29,151. Total number of shares owned as of Jun 26 were 78,611
Posted by on Friday February 05 2021, 6:16 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in